Charles River Laboratories International (CRL) Gross Margin (2009 - 2025)
Charles River Laboratories International (CRL) recorded quarterly Gross Margin of 74.93% in Q4 2025, up 26.17% quarter-over-quarter from 59.39% in Q3 2025, and up 11114.0% on a YoY basis from N/an in Q4 2024.
Charles River Laboratories International (CRL) Gross Margin (2009 - 2025) Analysis & Trends
Charles River Laboratories International's Gross Margin history runs 17 years deep, the most recent figure standing at 74.93% for Q4 2025.
- In Q4 2025, Gross Margin rose 11114.0% year-over-year to 74.93%; the TTM figure through Dec 2025 stood at 54.68% (up 1638.0% YoY), while the FY2025 annual figure was 85.65%, up 2755.0% from the prior year.
- Gross Margin was 74.93% for Q4 2025 at Charles River Laboratories International, up from 59.39% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 210.64% in Q4 2021 to a low of 36.22% in Q4 2024.
- Historically, Gross Margin has averaged 60.88% across 5 years, with a median of 47.66% in 2021.
- The sharpest annual moves came in 2022 and 2025: Gross Margin sank 16548 bps in 2022, then surged 11114 bps in 2025.
- A 5-year view of Gross Margin shows it stood at 210.64% in 2021, then tumbled by 79 bps to 45.16% in 2022, then surged by 52 bps to 68.57% in 2023, then sank by 153 bps to 36.22% in 2024, then surged by 307 bps to 74.93% in 2025.
- The last three Gross Margin figures came in at 74.93% (Q4 2025), 59.39% (Q3 2025), and 43.33% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 87.77% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 70.37% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 60.34% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 63.35% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 53.95% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 32.64% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 99.91% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 66.09% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 58.68% |
| 10 | Charles River Laboratories International | 9.26 Bn | 9.06 Bn | 744.94 Mn | 74.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | 74.93% |
| Sep 27, 2025 | 59.39% |
| Jun 28, 2025 | 43.33% |
| Mar 29, 2025 | 41.33% |
| Dec 28, 2024 | -36.22% |
| Sep 28, 2024 | 86.34% |
| Jun 29, 2024 | 43.73% |
| Mar 30, 2024 | 58.69% |
| Dec 30, 2023 | 68.57% |
| Sep 30, 2023 | 35.25% |
| Jul 1, 2023 | 37.64% |
| Apr 1, 2023 | 36.69% |
| Dec 31, 2022 | 45.16% |
| Sep 24, 2022 | 91.08% |
| Jun 25, 2022 | 46.29% |
| Mar 26, 2022 | 46.73% |
| Dec 25, 2021 | 210.64% |
| Sep 25, 2021 | 89.95% |
| Jun 26, 2021 | 89.52% |
| Mar 27, 2021 | 48.58% |